SLC25A4 Protein
Introduction <table class="infobox infobox-protein">
...
SLC25A4 Protein
Introduction <table class="infobox infobox-protein">
Slc25A4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[@fiore1998]
SLC25A4 (Solute Carrier Family 25 Member 4), also known as ANT1 (Adenine Nucleotide Translocator 1), is a mitochondrial carrier protein that facilitates the exchange of ADP and ATP across the inner mitochondrial membrane. [@brand2005]
Overview SLC25A4 is a critical component of the mitochondrial oxidative phosphorylation system, responsible for transporting ATP generated in the mitochondria to the cytosol while importing ADP for phosphorylation. This translocase is essential for cellular energy production and has been implicated in various neurodegenerative diseases. [@wallace2005]
Domain Structure
N-terminal matrix loop : Contains regulatory sequencesTransmembrane helices : 6 helices forming the poreMatrix loop : Substrate binding and transport cycleCytosolic loop : Regulatory interactionsMolecular Function
Transport Reaction The primary reaction catalyzed by SLC25A4:
ATP(out) + ADP(in) → ATP(in) + ADP(out)
This exchange is:
Electrogenic : 1:1 exchange of ATP⁴⁻ for ADP³⁻Bidirectional : Direction depends on cellular energy statusRate-limiting : Controls oxidative phosphorylation fluxEnzyme Properties
Role in Neurodegeneration
Parkinson's Disease
Dopaminergic neuron vulnerability : ANT1 dysfunction compromises ATP supplyMitochondrial complex I deficiency : Often coexists with ANT1 alterationsPINK1/PARKIN pathway : May regulate ANT1 expressionTherapeutic implications : Targeting ANT1 for neuroprotectionAlzheimer's Disease
Energy metabolism decline : Reduced ATP export capacity[Amyloid-beta](/proteins/amyloid-beta) interaction : Aβ may inhibit ANT1 functionCalcium dysregulation : Alters mitochondrial calcium handling with ANT1Amyotrophic Lateral Sclerosis
Motor neuron energy demands : High ATP requirements make [neurons](/entities/neurons) vulnerableMitochondrial dysfunction : ANT1 contributes to mitochondrial failureOxidative stress : ROS affects ANT1 function and expressionHuntington's Disease
Energy deficit : Mutant [huntingtin](/proteins/huntingtin) impairs mitochondrial functionANT1 dysregulation : Altered expression and function in HDTranscriptional disruption : HTT affects ANT1 gene regulationStructure-Function Relationships
Transport Mechanism
Binding : ADP/ATP binds to cytosolic sideConformational change : C-to-M or M-to-C transitionRelease : Substrate released to opposite sideReset : Carrier returns to initial conformation
Regulatory Mechanisms
Calcium : Matrix calcium modulates activityNucleotides : ATP and ADP provide feedback[Reactive oxygen species](/entities/reactive-oxygen-species) : Oxidative modification affects functionPhosphorylation : Post-translational regulationTherapeutic Approaches
Interactions
Complex I (ND subunits) : Functional couplingComplex V (ATP synthase) : Direct substrate channelingCreatine kinase : Energy buffering systemHexokinase : Cytosolic ATP utilizationVDAC : Outer membrane channelCyclophilin D : Mitochondrial permeability transitionExpression Pattern
Tissue Distribution
Brain Expression
Widely expressed in neurons
High in Purkinje cells
Detectable in glial cells
Region-specific variations
Biomarker Potential
Serum ANT1 : Possible biomarker for mitochondrial diseaseMutation detection : Genetic testing for SLC25A4 variantsFunctional assays : Lymphoblastoid cell studiesAnimal Models
ANT1 knockout mice : Show mitochondrial myopathyTransgenic models : Overexpression studiesConditional knockouts : Tissue-specific deletionSee Also
[SLC25A4 Gene](/genes/slc25a4)
[Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Mitochondrial ATP Synthesis](/mechanisms/mitochondrial-atp-synthesis)
[Mitochondrial Carriers](/proteins/mitochondrial-carrier-family)
External Links
[UniProt - SLC25A4](https://www.uniprot.org/) - Protein database
[OMIM - SLC25A4](https://www.omim.org/) - Genetic disorders
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Scientific literature
Background The study of Slc25A4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
Klingenberg M, (2008) (2008)
Fiore C, et al, (1998) (1998)
Brand MD, et al, (2005) (2005)
Wallace DC, (2005) (2005)
Brower JV, et al, (2019) (2019)
Milenkovic D, et al, (2013) (2013)
Azzu V, et al, (2010) (2010)
Palmieri L, et al, (2008) (2008) Show full description